| Outcome Measures: |
Primary: Area under the plasma glucose concentration curve (AUC) between 0 and 1 hour after insulin injection AUC(0-1h), At day 1 of each treatment period | Secondary: Area under the curve of plasma glucose concentration AUC(0-2h), At day 1 of each treatment period|Area under the curve of plasma glucose concentration AUC(0-4h), At day 1 of each treatment period|Area under the curve of plasma glucose concentration AUC(0-6h), At day 1 of each treatment period|Delta plasma glucose at 1h after standard meal, At day 1 of each treatment period|Maximum glucose concentration (GLU max), At day 1 of each treatment period|Maximum glucose excursion (delta GLU max), At day 1 of each treatment period|Time to delta GLU max, At day 1 of each treatment period|Time to fraction of total glucose AUC(10%, 20%), At day 1 of each treatment period|Area under the plasma insulin concentration curve AUC (0-1h), At day 1 of each treatment period|Area under the plasma insulin concentration curve AUC (0-2h), At day 1 of each treatment period|Area under the plasma insulin concentration curve AUC (0-4h), At day 1 of each treatment period|Area under the plasma insulin concentration curve AUC (0-6h), At day 1 of each treatment period|Maximum insulin concentration (Cmax), At day 1 of each treatment period|Time to fraction of total insulin AUC (10%, 20%), At day 1 of each treatment period|Time to Cmax, At day 1 of each treatment period|Hypoglycaemia and adverse events, from randomization to the end of study
|
